SCHEMBL7973932

SCHEMBL7973932

CCc1nc2ncn(Cc3ccc(-c4ccccc4)cc3)c2c(=O)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 2/20 0.52
TP53 P04637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
BRD4 O60885 3/20 0.45
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
TNKS2 Q9H2K2 1/20 0.42
EGLN1 Q9GZT9 1/20 0.41
PARN O95453 1/20 0.40
CNOT7 Q9UIV1 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
PNP P00491 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975251 0.93 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1HPGDKMT2ATP53
SCHEMBL7987432 0.87 HPGD (0.47) SMN1; SMN2ALDH1A1HPGDKMT2ATP53
SCHEMBL7987778 0.86 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1HPGDKMT2ATP53
SCHEMBL7988126 0.86 HPGD (0.49) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7984524 0.86 HPGD (0.52) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL8059820 0.85 HPGD (0.52) SMN1; SMN2ALDH1A1HPGDKMT2ATP53
SCHEMBL7985648 0.85 HPGD (0.47) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL21883489 0.84 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7984464 0.84 ABCC8 (0.50) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7989405 0.83 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed